Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Axcelis Technologies jumps as investors refocus on Veeco merger progress and recent company updates

None

Axcelis Technologies, Inc. (ACLS) is up 10.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The day’s sharp move appears more consistent with a sentiment-driven rebound than a single new headline. Investors have recently been weighing Axcelis’ pending all-stock merger with Veeco, integration planning updates disclosed in merger-related SEC communications, and a management transition in the CFO seat. This could also be amplified by short-covering and momentum trading after prior volatility in semiconductor equipment names.

Details:

  • Axcelis said stockholders approved proposals related to its pending merger with Veeco, with closing still subject to customary conditions including remaining regulatory approval in China, and the companies continued to expect completion in the second half of 2026.
  • A merger-related SEC communication described ongoing integration planning, including an “Integration Summit” with employees from both companies and a status update that multiple regulatory approvals had already been obtained while others remained in process.
  • Axcelis announced a CFO transition in March 2026, naming David Ryzhik as interim CFO effective March 12, 2026, and stating that outgoing CFO James Coogan planned to remain through April 24, 2026 to support the transition.
  • Axcelis introduced the Purion H6 high-current ion implanter in February 2026, positioning it as a next-generation platform aimed at advanced device manufacturing needs.
  • Sources:

    Axcelis Investor Relations, U.S. Securities and Exchange Commission

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ACLS Insider Trading Activity

    ACLS Insider Trades

    $ACLS insiders have traded $ACLS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

    Here’s a breakdown of recent trading of $ACLS stock by insiders over the last 6 months:

    • GERALD M BLUMENSTOCK (EVP, Research, Dev. & Eng.) sold 3,034 shares for an estimated $271,421
    • JORGE TITINGER has made 0 purchases and 2 sales selling 3,000 shares for an estimated $252,100.
    • RUSSELL LOW (PRESIDENT AND CEO) has made 0 purchases and 2 sales selling 2,488 shares for an estimated $228,970.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    EARLY ACCESS
    Receive ACLS Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $ACLS Hedge Fund Activity

    We have seen 174 institutional investors add shares of $ACLS stock to their portfolio, and 173 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $ACLS Price Targets

    Multiple analysts have issued price targets for $ACLS recently. We have seen 2 analysts offer price targets for $ACLS in the last 6 months, with a median target of $95.5.

    Here are some recent targets:

    • Craig Ellis from B. Riley Securities set a target price of $91.0 on 02/18/2026
    • Duksan Jang from B of A Securities set a target price of $100.0 on 01/13/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles